U-M hepatologist hails hepatitis B treatment trial results
Peer-Reviewed Publication
Updates every hour. Last Updated: 22-Jun-2026 11:16 ET (22-Jun-2026 15:16 GMT/UTC)
University of Michigan Health hepatologist Anna S. Lok, M.D., hails newly announced results of the B-Well clinical trials as “a major step toward a functional cure for hepatitis B virus infection," in an editorial published in the New England Journal of Medicine.
A recent study from The University of Texas at San Antonio reveals that low-cost training for frontline health workers can significantly reduce medical supply shortages, potentially saving thousands of lives in developing nations.
Metabolic regulation at the maternal-embryo interface is essential for successful embryo implantation, yet its dynamics in humans remain poorly understood because of ethical and technical constraints. Researchers established a physiologically relevant maternal-embryo interaction model by co-culturing human blastoids with 3D endometrial assembloids, enabling analysis of metabolic changes during the implantation window. The study provides a systematic view of metabolic dynamics at the human maternal-embryo interface, identifies lipid remodeling and arachidonic acid (ARA) metabolism as key regulators of maternal and embryonic responses during implantation, and offers a mechanistic basis for diagnosis and metabolic intervention strategies in implantation failure.
Atopic dermatitis (AD), the most common form of eczema, impacts patients’ life trajectories beyond the physical scars. A novel study shows that adults with AD, particularly those with childhood onset, report significantly greater limitations in their educational and professional choices, with up to 38% of childhood-onset patients reporting career restrictions and more than 36% reporting constrained study choices, compared to individuals whose disease began in adulthood. The findings of the new study in the Journal of Investigative Dermatology (JID), published by Elsevier, provide a scientific basis for more comprehensive, early, and multidimensional care that goes beyond symptom control for patients with AD.